Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like the stock is heading down towards .05 per share over the next month. Good opportunity to buy before IND submission sometime this summer.
FDA approval will happen.
This is great news for PC patients. We need more of this kind of news. Hopefully we get something similar from PMCB at years end.
Happy Easter to all
I think the company leadership along with their partners are working hard to submitt the IND this year. By summer or fall is when I expect that they will have everything ready to go. Then, things will hopefully move along with trial; otherwise, the stock will start to quickly decline.
There is no reason to buy or sell this stock at this time. This is a buy and hold until news of IND is announced. If no IND news this year then the stock will tank.
You have my vote for PMCB
I'd rather they not create noise with all of these other not so news worthy PR's. They seem to be spread all over the place and not focused. I don't want news that is no real news and continues to attract shorts. Stick to the main business on hand(IND). Otherwise it looks like thet are just putting out PR's to distract.
I too don't think IND filing will take place until June. I agree with Pete in that it seems to be set up for end of year results or sooner if positive results. There is a lot to do in getting the IND right as they only have one shot at making sure it doesn't get hung up with FDA. I also believe that if IND is approved by FDA there will be interest for a potential buyout before the end of the 6 month stop.
I own lots of real biotech stock... This stock is in my portfolio and confident that it will improve from .10 PPS in 1 or 2 years from now. I like your posts at times as you try to keep everyone honest and realistic. I think nan invest in penny stocks to get rich quick. The real world doesn't work this way. diversify is something that all need to do.
No one on this board knows when the PPS will hit any price...it's all guess work at this point. If news about IND progress is announced or IND filing is announced the PPS may go up to pre IND range of .15....then it will go down again as profits will be taken. Only a handful of investors really believe in the successful outcome of the trial and will hold on for big money. I don't care about the daily price changes of technical analysis on this stock. Only thing that matters is positive outcome of the trial or buyout announcement.
I've been here and not going anywhere. Waiting for pivotal trial and outcones and the rest will take care of itself. Anything prior to the pc trial is speculative in my view. Market cap drives what PPS will be with successful pivotal trial and that is expected 5 year revenue value discounted to today which puts the PPS at approximately 2.50 to 5.00.. Best guess.
I don't know if anything is about to happen. All speculation at this point just like pre CC. If there is something going on I don't believe the company' smarter cap is going to be worth much more than what it is today.
If KW is looking to sell at this point that to me is a big red flag because he doesn't believe the company will be around for the long haul.
Yeah right.. I got a bridge to sell
Where is all the buyout talk coming from.. The company's not worth more than 10cents per share, if that, without the trial. Or, is this just those on this board hyping things up.
I bought and will stay until IND is filed and pivotal is on. Maybe then the company is going to be worth some real money.
I don't get it.. What is the purpose of today's post? This is NOT news to those who know anything about IND applications for a pivotal trial (which takes months to prepare for submission). I am beginning to think that KW is more interested in PRs to passify those true penny shareholders who buy and sell trying to make a few thousand dollars each month versus true shareholders who believe in the technology and expected positive trial outcones. I am not aware of any company who puts PR's that it's intended consequences is to drive the PPS down (idiotic!) or is it intentional?
That is what I have been saying since the CC. I only invested a significant amount of money after I heard pivotal trial. I believe Bears was questioning my post last week about FDA has not approved anything. Yeah, of course they didn't approve anything until the IND is filed, reviewed, and approved but the point is that PMCB expected an exploratory trial discussion and subsequent filing and not Pivotal and FDA said pivotal.
Yes. That's why I don't want to see any PR's that provide NO news or recycled old information that has people question this company's efforts to get the IND submission right. Pivotal trials require a lot of pieces to be in place so I have to trust that the PMCB leadership is heads down to get everything right. I only care about trial start date and outcomes. The PPS will then take care of itself.
I don't want any PRs that provide no news. I am not sure why we expect the IND to be filed in less than 2 months from the meeting with the FDA. PMCB expectation was exploratory trial IND submission and then it turned into a pivotal trial and they only have one shot to do it right. I don't expect any news in IND until
late April.
Can you provide some clinical trial outcomes? Links to the trials? Is TD2 or Dr. Hidalgo involved... If it's big pharma wil love to see their PRs on this
I agree regarding ability to raise funding since this is a pivotal trial. Pharmacyte's 10-K is expected to be available on 3/13 or before. Eager to hear about the financials. Pivotal trial funding is one of those big unknows for me. I can deal with the IND submission timelines to take months to complete so hoping funding will also be in place for the trial.
I don't believe it's the paperwork (documentation) as they have consultants doing that it's the pivotal trial prepardness that takes time (getting the sites ready for patients for CypCas technology). Keep in mind that the PreIND submissions and PR hype until the conference call was all about the exploratory trial. This IND submission would have been quicker.
I afmitted to those on this board that I was not an investor in an OTC penny stock until pivotal was announced. This was the Landmark comment from KW because he didn't expect this.
Pivotal trial IND takes a few months to prepare as once approved by FDA then you can start the trial 30 days later. Doesn't make sense to file IND if you are not ready to start the trial a month later. To get IND approval for pivotal trial everything must be in order and sites ready to treat patients. There is hope that IND is filed soon (this month) but I expect the IND to be filed by the end of April or May. And this would be great as we mag have results in 2017.
This is an OTC company going to pivotal trial which is phenomenal. Patients are waiting for this technology to help them and FDA saw value in it and approved the pivotal trial. Think about it, if exploratory trial was approved (as initially planned) we would be talking about potential 2019 or 2020 for the product to go to market now it's potentially 2018. Even the big pharma companies started this way (1980s in the case of Celegene).
It seems that even those posting on this board are like other individual investors in penny stocks (buy and sell) on PPS downs and ups. I am not that sophisticated on buying and selling but do know that the profits gained in the short term will not be anything close to the profits I expect to realize in the long run. Pivot trial IND takes much longer to file and it must be done right. Then all timelines fall into place. Outcomes from the trial will equal real profits.
If you want to make some money then one should invest in mutual funds and blue chip stocks. However, the risk vs. reward is not going to be as great as a penny stock when there is REAL news ( pivotal trial positive outcomes). I also invest in blue chips and make money but this will pale in comparison to the amount to be made with PMCB. Sirius XM was once .25 cents what's the price today.. Many cashed in on that stock too early.
There is nothing to discredit. I will continue to post similar messages since the CC. FDA gets it and requests that PMCB go for Pivotal trial. This is Big Leagues. KW should NOT continue to provide PR's that is NO news. To get to pivotal everything they planned to submitt in their initial IND has to be reworked for Pivital.
TD2 and Austrianova and the principal investigators all have to work together. This takes months to complete. All should be looking at the end game ( overall survival rates) equals buyout by Big Pharma. Taking profits sooner is not wise.
No I did not...I was being conservative on the actual PPS estimates. I like to tie everything to market cap.. As this is the marker that big pharma will use for the buyout.
Agreed. I've posting the same since the CC.
There is something going on with this stock in terms of PPS and hope the leadership can address this soon. The financials are due by or before March 13 so looking to see what KW has in store.
IND filing, start of trial, and patient enrollment will potentially increase PMCB's market cap by 3 to 4x the current PPS or .30 to .40 PPS on the very top end. It's not PPS it's the market cap that needs to be evaluated.
The real numbers are the positive trial outcomes and the fast track which will make this company attractive to big pharma and then the value for PC woul be between 3 to 5 per share ( or 3 to 5 billion market cap).
This is how I say if play out.
I agree with you that PPS will spike on announcements ( IND, etc..) and then a whole bunch of individual investors will start to take profits and the PPS will go down again, etc..
The real money for most will be when positive outcomes are announced.
PMCB may be followng the same path as Tocagen with the FDA once pivotal trial starts and results begin to be announced. Break through and fast track designation is what will most likely occur. The FDA is aware that hundreds of thousands of patients suffering from deadly cancers need such companies to be successful.
I did my own due diligence and only invested when I heard the CC and Pivotal trial. Pivotal trial puts PMCB in the Big Leagues. Not many biotech at this price point have a pivotal trial in the horizon. If the FDA saw the value based on the materials presented (including previous trial outcomes) then why not believe in the company. And, more institutional investors will be buying in the coming months.
In my view, institutional investors with small positions will continue to come as they are much smarter then most individual investors who buy penny stocks on Monday and sell on Fridays. That is the problem with this penny stock (as it's still viewed a penny stock). If people did their research on PMCB hey would have bought a ton of shares after the CC as I did. I admit I am not a long as most of you are on this board and I applaud you for staying with this penny stock for all these years. I never invest in penny stock EXCEPT PMCB.
I think the IND filing announcement will cause a bump on the PPS. Not many who buy and sell this stock are reading this board. If they did they would hold on to their shares until the trial outcomes are announced.
I totally agree. I am one of those on this board that bought a significant amount of shares after the CC because once I heard FDA thought the trial shoud be a PIVOTAL trial I knew that there is real value with the compan. I also knew that the entire IND submission process will take much longer to file and getting the trials started even longer then that. My main concern has and will continue to be funding for Pivotal trial. So, once more clarity on this is provided then in my opinion all should HOLD and wait for this stock to rocket.
TD2 follows the same process for all of their clients when hired as the CRO. They get paid to do all of the things listed on the PR. Not news. It hurts PPS because those who are investing in a penny stock just to make a few dollars will leave as they don't understand the lengthy process that is required for a PIVOTAL trial.
These trials take not months but years (in PCMB case maybe 1 year from start of the trial to patient enrollment to outcome measurements).
IND is just process and may increase PPS in the short term but one should not invest in this company if they don't believe in the positive outcomes expected from the technology. Then the PPS will take care of itself (company will be purchased).
More visibility re: institutional investors..
http://www.nasdaq.com/symbol/pmcb/institutional-holdings/increased
Great Post. Also, how many of the other companies in this ETF are going to have a PIVOTAL trial in the near future ..
I totally agree. It's all about operable tumors becoming operable.